W.L. Gore & Associates, Inc. v. Medtronic, Inc.

778 F. Supp. 2d 667, 2011 U.S. Dist. LEXIS 44941, 2011 WL 1541312
CourtDistrict Court, E.D. Virginia
DecidedApril 20, 2011
DocketCivil Action 2:10cv441
StatusPublished
Cited by12 cases

This text of 778 F. Supp. 2d 667 (W.L. Gore & Associates, Inc. v. Medtronic, Inc.) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
W.L. Gore & Associates, Inc. v. Medtronic, Inc., 778 F. Supp. 2d 667, 2011 U.S. Dist. LEXIS 44941, 2011 WL 1541312 (E.D. Va. 2011).

Opinion

OPINION AND ORDER

MARK S. DAVIS, District Judge.

This matter is before the Court on Defendants’ Medtronic, Inc., Medtronic USA, Inc., and Medtronic Vascular, Inc. (collectively “Defendants” or “Medtronic”) motion to dismiss pursuant to Rules 12(b)(2) and 12(b)(6) of the Federal Rules of Civil Procedure. 1 After examining the motion, associated briefs, and the Complaint, the Court finds that oral argument is unnecessary because the facts and legal contentions are adequately presented and oral *669 argument would not aid in the decisional process. Fed.R.Civ.P. 78(b); E.D. Va. Loc. R. 7(J). Therefore, the matter is now ripe for decision and, for the reasons set forth below, Defendants’ motion to dismiss is DENIED. However, as discussed below, Plaintiffs are hereby GRANTED leave to amend the Complaint by May 6, 2011 with respect to allegations of indirect infringement.

I. Facts and Procedural History 2

Plaintiffs W.L. Gore & Associates, Inc. and Gore Enterprise Holdings, Inc. (collectively “Plaintiffs” or “Gore”) have brought an action for patent infringement involving United States Patent No. 5,810,870 (the “'870 patent”). The '870 patent, entitled “Intraluminal Stent Graft,” was issued on September 22, 1998 to David J. Myers, James D. Lewis, Wayne D. House and Karl E. Schwarz. Compl. ¶ 11. While the patent was issued to the above mentioned individuals, Gore Enterprise Holdings is the “owner of all right, title and interest in the '870 patent” and W.L. Gore & Associates, Inc. is the “licensee of the '870 patent with rights to practice the '870 patent in the United States.” Compl. ¶¶ 12-13.

On September 3, 2010, Plaintiffs brought an action for patent infringement against Defendants in this Court under 35 U.S.C. § 271(a), (b) and (c). The Complaint initiating this action includes only one count. This count alleges that Defendants have committed direct and indirect patent infringement. Specifically, the Complaint alleges that Defendants “make, use, sell, and/or offer for sale the Talent Abdominal Stent Graft and the Talent Thoracic Stent Graft.” Compl. ¶ 14. In performing such actions, Plaintiffs allege that Defendants are “infringing, inducing infringement, and/or contributing to the infringement of the '870 patent ... and/or inducing or contributing to the use by others of such devices covered by the '870 patent, all to the injury of Gore.” Compl. ¶ 16. Plaintiffs further allege that Defendants’ “infringement has been willful and will continue to be willful, making this case exceptional and entitling Gore to increased damages and other relief pursuant to 35 U.S.C. §§ 284 and 285 of the patent statute, to any extent not prohibited by the Agreement.” Compl. ¶ 18.

The agreement to which the Complaint refers is a Settlement and License Agreement (“Agreement”) struck between the parties on August 28, 2009. Compl. ¶ 8. According to this Agreement, which was attached to Plaintiffs’ memorandum in opposition to the motion to dismiss, “with respect to patent infringement and/or patent invalidity claims relating to or arising from any of Medtronic’s cardio vascular businesses, the Parties agree to bring such actions in the United States District Court for the Eastern District of Virginia....” Mem. Opp’n. Mot. Dismiss Ex. A, at 11. If, however, the United States District Court for the Eastern District of Virginia lacks subject matter jurisdiction, the Agreement states that “the Parties shall confer in good faith on the selection of an alternative neutral forum for such action.” Id. As to damages available in future disputes, the Agreement provides that “the Parties agree ... to waive their right to jury trial and to waive their rights to seek *670 an injunction, exemplary damages and attorneys’ fees as to any patent infringement or patent invalidity disputes.” Id. By dint of this Agreement, and the facts alleged in the Complaint, Plaintiffs contend that this Court has personal jurisdiction over the Defendants. Compl. ¶ 9.

On November 19, 2010, Defendants filed a motion to dismiss the Plaintiffs’ Complaint. In this motion, Defendants seek dismissal of the Complaint because it allegedly “inappropriately relies on and fails to comply with provisions” of the Agreement and because “the Complaint fails to meet the minimum pleading requirements set forth in the Federal Rules of Civil Procedure and by the Supreme Court decisions of Twombly and Iqbal.” Mot. to Dismiss, Docket No. 18. It is this motion that the Court addresses below.

II. Discussion

1. Personal Jurisdiction and Limitations in the Agreement

A. Personal Jurisdiction

The Defendants’ first argument in their motion to dismiss is that the Complaint improperly relies on the Agreement to establish personal jurisdiction. The entire personal jurisdictional allegation in Plaintiffs’ Complaint states that the agreement “stipulates that, during the term of the Agreement, any action for patent infringement brought by one of the parties against another of the parties shall be brought in the United States District Court for the Eastern District of Virginia.” Compl. ¶ 8. Plaintiffs’ Complaint further asserts that, as a result of such provision, “this Court has personal jurisdiction over defendants .... ” Compl. ¶ 9. According to the Defendants, “Gore fails to plead the basis under which this Court would have personal jurisdiction over Defendants. Instead, Gore simply cites the Agreement and then alleges that the facts and causes alleged in the Complaint give rise to personal jurisdiction over Defendants.” Mem. Supp. Mot. Dismiss 3. In response, Plaintiffs argue, among other things, that Defendants consented to jurisdiction in this forum when they agreed to the forum selection clause in the Agreement between the parties. Mem. Opp’n. Mot. Dismiss 5.

In order to evaluate Defendants’ assertions, the Court must first determine the applicable law on the subject of personal jurisdiction in patent cases. According to the Federal Circuit, “[i]n reviewing district court judgments in patent cases, this court applies its own law on patent law issues, but with respect to nonpatent issues it generally applies the law of the circuit in which the district court sits.” Phonometrics, Inc. v. Hospitality Franchise Sys., 203 F.3d 790, 793 (Fed.Cir.2000). While personal jurisdiction might appear to be a nonpatent issue at first glance, the Federal Circuit has held that with respect to personal jurisdiction, it applies “ ‘Federal Circuit law because the jurisdictional issue is ‘intimately involved with the substance of the patent laws.’ ”

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Faryniarz v. Ramirez
62 F. Supp. 3d 240 (D. Connecticut, 2014)
Macronix International Co. v. Spansion Inc.
4 F. Supp. 3d 797 (E.D. Virginia, 2014)
Virginia Innovation Sciences, Inc. v. Samsung Electronics Co.
983 F. Supp. 2d 700 (E.D. Virginia, 2013)
Auburn University v. International Business Machines, Corp.
864 F. Supp. 2d 1222 (M.D. Alabama, 2012)
Gradient Enterprises, Inc. v. Skype Technologies S.A.
848 F. Supp. 2d 404 (W.D. New York, 2012)
W.L. Gore & Associates, Inc. v. Medtronic, Inc.
850 F. Supp. 2d 630 (E.D. Virginia, 2012)
NIELSEN CO.(US), LLC v. comScore, Inc.
819 F. Supp. 2d 589 (E.D. Virginia, 2011)

Cite This Page — Counsel Stack

Bluebook (online)
778 F. Supp. 2d 667, 2011 U.S. Dist. LEXIS 44941, 2011 WL 1541312, Counsel Stack Legal Research, https://law.counselstack.com/opinion/wl-gore-associates-inc-v-medtronic-inc-vaed-2011.